Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hot Products

SeraNovo Enters into License Agreement with Carna Biosciences for Development of Oral Formulation of Carna's Kinase Inhibitor

b3cnewswireOctober 31, 2019

Tag: SeraNovo , Carna , kinase inhibitor , Oral

PharmaSources Customer Service